Literature DB >> 1323014

The human 5-HT2 receptor is encoded by a multiple intron-exon gene.

K Chen1, W Yang, J Grimsby, J C Shih.   

Abstract

Serotonin (5-hydroxytryptamine; 5-HT) mediates many central and peripheral nervous system functions by its interaction with specific neuronal receptors. Here we report the genomic structure of the human 5-HT2 receptor. The SacI-EcoRI restriction fragment of rat 5-HT2 receptor cDNA was used as a probe to identify and isolate two positive clones of 8.5 and 7.0 kb from an EcoRI restriction digest of a chromosome 13 specific EcoRI fragment lambda-phage human genomic library. Subcloning and sequencing of these fragments showed the 8.5 kb fragment (designated lambda SE-5) contained the first two exons of the 5-HT2 receptor gene. The 7.0 kb insert (lambda SE-2) contained an incomplete third exon. A HindIII-EcoRI fragment of this insert was used as a probe to isolate a 9.0 kb clone (lambda SH-2), which contained the entire third exon, from a chromosome 13 specific HindIII-fragment lambda-phage human genomic library. The isolation of these three clones (lambda SE-5, lambda SE-2 and lambda SH-2) shows that the human 5-HT2 receptor gene consists of three exons separated by two introns and spans over 20 kb. The deduced amino acid sequence of the human, mouse and rat 5-HT2 receptors are highly conserved and all three share a 90% sequence similarity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323014     DOI: 10.1016/0169-328x(92)90005-v

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

1.  Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia.

Authors:  J Erdmann; D Shimron-Abarbanell; M Rietschel; M Albus; W Maier; J Körner; B Bondy; K Chen; J C Shih; M Knapp; P Propping; M M Nöthen
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

Review 2.  Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia.

Authors:  Ibrahim Mohammed Badamasi; Munn Sann Lye; Normala Ibrahim; Johnson Stanslas
Journal:  J Neural Transm (Vienna)       Date:  2019-05-18       Impact factor: 3.575

Review 3.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

4.  Family-based association study of the serotonin-2A receptor gene (5-HT2A) and bipolar disorder.

Authors:  Xingqun Ni; Joseph M Trakalo; Emanuela Mundo; Lisa Lee; Sagar Parikh; James L Kennedy
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 4.103

Review 5.  5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy.

Authors:  Hongyan Zhao; Yang Lin; Shurui Chen; Xin Li; Hongliang Huo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis.

Authors:  Yuan-Sheng Wan; Xue-Jia Zhai; You-Sheng Ai; Li-Bo Zhao; Hong-Ai Tan
Journal:  Pharmacogenomics J       Date:  2020-10-23       Impact factor: 3.550

7.  Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons.

Authors:  Cara L Ruble; Ryan M Smith; John Calley; Leanne Munsie; David C Airey; Yuan Gao; Joo Heon Shin; Thomas M Hyde; Richard E Straub; Daniel R Weinberger; Laura K Nisenbaum
Journal:  BMC Genet       Date:  2016-01-06       Impact factor: 2.797

Review 8.  The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.

Authors:  Baland Jalal
Journal:  Psychopharmacology (Berl)       Date:  2018-10-05       Impact factor: 4.530

9.  Assessment of Pain Sensitivity in Patients With Chronic Low Back Pain and Association With HTR2A Gene Polymorphism.

Authors:  Saliha Handan Yildiz; Alper Murat Ulaşli; Müjgan Özdemir Erdoğan; Ömer Dikici; Evrim Suna Arikan Terzi; Ümit Dündar; Mustafa Solak
Journal:  Arch Rheumatol       Date:  2016-08-17       Impact factor: 1.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.